André Mansinho - Concepedia

Author

André Mansinho

Hospital de Santa Maria ORCID

Also Known As

A Mansinho, A. Mansinho, A.B. Mansinho, Andre Mansinho, André Mansinho, Mansinho, André, Pedro Madeira

104

Publications

964

Citations

H-Index

Concepts

All Affiliations

Hospital de Santa Maria Centro Hospitalar Lisboa Norte University of Lisbon Illumina (United States)Universidade Nova de Lisboa

About

André Mansinho is an author at Hospital de Santa Maria specializing in oncology, medicine, and molecular oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	53
2	Immunology	1	1	26
3	Pathology	1	1	27
4	Cancer Therapeutics	1	1	27
5	Clinical Trials	1	1	26

André Mansinho

Publications

252

Citations

H-Index

Page 1

	Year	Citations
Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development Daniel Sobral, Marta Martins, Shannon Kaplan, Communications Biology	2022	36
HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome Mahdi Golkaram, Michael Salmans, Shannon Kaplan, npj Genomic Medicine	2021	33
Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases André Mansinho, Arlindo R. Ferreira, Sandra Casimiro, International Journal of Molecular Sciences	2019	30
Anti-EGFR Therapy to Treat Metastatic Colorectal Cancer: Not for All Marta Martins, André Mansinho, Raquel Cruz-Duarte, Advances in experimental medicine and biology Gastrointestinal OncologyMedicineColorectal CancerAnti-egfr TherapyPathology	2018	27
Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases Arlindo R. Ferreira, M. Bettencourt, Irina Alho, Journal of bone oncology	2017	26
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer Inês Gomes, Bernardo P. de Almeida, Sara Dâmaso, Oncotarget	2020	26
Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes Lisa Gonçalves, Duarte Gonçalves, Teresa Esteban-Casanelles, Cells ImmunologyImmunoeditingImmunotherapeuticsDermatologyImmunotherapy	2023	26
Predictive and therapeutic implications of a novel PLCγ1/SHP2-driven mechanism of cetuximab resistance in metastatic colorectal cancer Raquel Cruz-Duarte, Cátia Rebelo de Almeida, Magda Negrão, Repositório da Universidade de Lisboa (University of Lisbon)	2022	14
Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization Carolina Peixoto, Marta B. Lopes, Marta Martins, BMC Bioinformatics	2023	13
Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer Inês Gomes, Lina M. Gallego-Paez, María Jiménez, Cell Reports Medicine	2023	11

Page 1